Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. We have a diversified and growth-oriented commercial product portfolio. Key therapeutic areas are Inflammation and Genetics & Metabolism. Our late stage pipeline includes three phase III programs with substantial potential. We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners. Our sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand. In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com.
View Top Employees from Swedish Orphan Biovitrum AB (Sobi)Website | http://www.sobi.com |
Ticker | SOBI |
Revenue | $1.61 billion |
Funding | $152.5 million |
Employees | 161 (104 on RocketReach) |
Founded | 2001 |
Phone | (468) 697-2000 |
Fax | (468) 697-2330 |
Technologies |
JavaScript,
HTML,
PHP
+42 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Manufacturing & Research, Dedicated to rare diseases, Science and Engineering, Drug Discovery, Key therapeutic areas are Inflammation and Genetic diseases, wit, Healthcare, Genetics, A pioneer in biotechnology with world-class capabilities in prot, Medical Testing & Clinical Laboratories, Health Care |
Web Rank | 2 Million |
Keywords | Biotechnology, Rare Disease, Biologics, Pharmaceutical Manufacturing, Therapeutic Activities, Autoimmune Disease, Pharmaceutical Services |
Competitors | 3SBio Inc., Amneal Pharmaceuticals, Dr Reddy's NZ Ltd, Endo International plc, Recordati |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Swedish Orphan Biovitrum AB (Sobi) employee's phone or email?
The Swedish Orphan Biovitrum AB (Sobi) annual revenue was $1.61 billion in 2024.
Carin Dahlquist is the Senior Director, Legal Affairs of Swedish Orphan Biovitrum AB (Sobi).
104 people are employed at Swedish Orphan Biovitrum AB (Sobi).
Swedish Orphan Biovitrum AB (Sobi) is based in Ase, Vasternorrlands Lan.
The NAICS codes for Swedish Orphan Biovitrum AB (Sobi) are [3254, 32, 32541, 325].
The SIC codes for Swedish Orphan Biovitrum AB (Sobi) are [28, 283].